E-LIB Suche - Ergebnisse für: Dayno, Jeffrey M

1

Clinical Impact of Pitolisant on Excessive Daytime Sleepine..:

Meskill, Gerard J. ; Davis, Craig W. ; Zarycranski, Donna...
CNS Drugs. 36 (2021) 1 - p. 61-69 , 2021

Link: https://doi.org/10.1007/..

2

Time to Onset of Response to Pitolisant for the Treatment o..:

Watson, Nathaniel F. ; Davis, Craig W. ; Zarycranski, Donna...
CNS Drugs. 35 (2021) 12 - p. 1303-1315 , 2021

Link: https://doi.org/10.1007/..

3

Evaluation of the abuse potential of pitolisant, a selectiv..:

Schwartz, Jean-Charles ; Dayno, Jeffrey M ; Robert, Philippe...
Sleep. 43 (2019) 4 - p. , 2019

Link: https://doi.org/10.1093/..

4

0612 Evaluation of Abuse Potential of the Narcolepsy Medica..:

Dayno, Jeffrey M ; Scart-Grès, Catherine ; Robert, Philippe..
Sleep. 42 (2019) Supplement_1 - p. A243-A244 , 2019

Link: https://doi.org/10.1093/..

5

0611 The Safety and Tolerability of Pitolisant in the Treat..:

Bauer, Eric D ; Davis, Craig W ; Patroneva, Albena..
Sleep. 42 (2019) Supplement_1 - p. A243-A243 , 2019

Link: https://doi.org/10.1093/..

6

The ALERRT® instrument: a quantitative measure of the effor..:

Cone, Edward J. ; Buchhalter, August R. ; Lindhardt, Karsten..
The American Journal of Drug and Alcohol Abuse. 43 (2017) 3 - p. 291-298 , 2017

Link: https://doi.org/10.1080/..

7

Human Abuse Potential of an Abuse-Deterrent (AD), Extended-..:

Webster, Lynn R. ; Smith, Michael D. ; Lawler, John..
Pain Medicine. , 2016

Link: https://doi.org/10.1093/..

8

Poster 420 Pharmacodynamic Effects from a Category 3 Oral H..:

Smith, Michael D. ; Webster, Lynn R. ; Lawler, John..
PM&R. 8 (2016) 9S - p. , 2016

Link: https://doi.org/10.1016/..

9

Poster 427 Pharmacodynamic Effects From a Category 3 Intran..:

Webster, Lynn R. ; Smith, Michael D. ; Lawler, John..
PM&R. 8 (2016) 9S - p. , 2016

Link: https://doi.org/10.1016/..

10

Poster 457 Bioequivalence and Food Effect of a Novel, Abuse..:

Dayno, Jeffrey M. ; Lawler, John ; Niebler, Gwendolyn.
PM&R. 8 (2016) 9S - p. , 2016

Link: https://doi.org/10.1016/..

11

Poster 416 Dissolution Studies in the Presence of Alcohol w..:

Elhauge, Torben ; Kristensen, Lene ; Dayno, Jeffrey M..
PM&R. 8 (2016) 9S - p. , 2016

Link: https://doi.org/10.1016/..

12

Human Abuse Potential of an Abuse-Deterrent (AD), Extended-..:

Smith, Michael D. ; Webster, Lynn R. ; Lawler, John..
Pain Medicine. , 2016

Link: https://doi.org/10.1093/..

13

Treating Early Versus Treating Mild: Timing of Migraine Pre..:

Foley, Kathleen A. ; Cady, Roger ; Martin, Vincent...
Headache: The Journal of Head and Face Pain. 45 (2005) 5 - p. 538-545 , 2005

Link: https://doi.org/10.1111/..

14

What Do Patients With Migraine Want From Acute Migraine Tre..:

Lipton, Richard B. ; Hamelsky, Sandra W. ; Dayno, Jeffrey M.
Headache: The Journal of Head and Face Pain. 42 (2002) s1 - p. 3-9 , 2002

Link: https://doi.org/10.1046/..

15

Intravenous Tissue Plasminogen Activator for Acute Ischemic..:

Tanne, David ; Gorman, Mark J. ; Bates, Vernice E....
Stroke. 31 (2000) 2 - p. 370-375 , 2000

Link: https://doi.org/10.1161/..